Key facts
- It has raised $13.0M; the latest was Seed Round ($13.0M) in Nov 2025.
- Notable investors include Khosla Ventures, Speedinvest, Jeff Dean, Fifty Years, Script Capital (United States) — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Onepot
- ·The full record, as it builds
Funding rounds
No funding rounds for Onepot are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Onepot
Developer of an AI-driven chemical synthesis platform designed to advance research and experimentation in biotechnology and pharmaceuticals. The company's platform integrates machine learning for predicting and optimizing chemical reactions, synthesis capabilities, rapid turnaround for custom molecule production, large-scale data generation on chemical reactivity, and automated experimentation workflows, enabling researchers, drug developers, and materials scientists to access vast chemical libraries and accelerate discovery processes.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 4
- Website
- onepot.ai/
- Ownership
- Privately Held (backing)
Onepot doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Onepot shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Onepot in its N-PORT filings yet. We sweep new filings monthly.